Yu Wei

8PUBLICATIONS
24CO-AUTHORS
Medical virologyMedical molecular engineering of nucleic acids and proteinsMolecular targetsVirology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 15, 2025
CDC42 supports HBV entry by NTCP translocation to the plasma membrane and macropinocytosis.

Shuzhi Cui, Wei Gao, Yuxin Chen

|Dec 09, 2024
Enhanced hepatitis B virus-specific immunity by combining neutralizing antibody therapy and DNA vaccination in a murine model of chronic hepatitis B virus infection.

Maxime Beretta, Benjamin Vesin, Yu Wei

|May 16, 2024
CALCOCO2/NDP52 associates with RAB9 to initiate an antiviral response to hepatitis B virus infection through a lysosomal degradation pathway.

Shuzhi Cui, Mathias Faure, Yu Wei

|Dec 19, 2023
NDP52 mediates an antiviral response to hepatitis B virus infection through Rab9-dependent lysosomal degradation pathway.

Shuzhi Cui, Tian Xia, Jianjin Zhao

Pageof 2

Frequent Collaborators

4 joint publications

Anne Dejean

4 joint publications

Pierre Sonigo

4 joint publications

Marie-Louise Michel

4 joint publications

Jean Weissenbach